当前位置:首页 - 行情中心 - 基蛋生物(603387) - 财务分析 - 现金流量表

基蛋生物

(603387)

  

流通市值:41.23亿  总市值:41.23亿
流通股本:5.07亿   总股本:5.07亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金530,229,843.98257,759,724.661,332,123,995.761,018,494,769.47
  收到的税费返还849,799.74847,823.199,666,506.4412,957,614.07
  收到其他与经营活动有关的现金29,309,721.319,482,736.6852,413,814.4393,698,631.88
  经营活动现金流入小计560,389,365.03268,090,284.531,394,204,316.631,125,151,015.42
  购买商品、接受劳务支付的现金73,808,358.5234,212,792.59249,022,932.31328,502,791.59
  支付给职工以及为职工支付的现金190,730,779.28117,192,677.27396,590,582.21299,738,672.13
  支付的各项税费54,723,103.5321,743,147.54100,915,126.7878,514,429.07
  支付其他与经营活动有关的现金93,941,087.2846,087,916.79224,677,619.51168,488,077.41
  经营活动现金流出小计413,203,328.61219,236,534.19971,206,260.81875,243,970.2
  经营活动产生的现金流量净额147,186,036.4248,853,750.34422,998,055.82249,907,045.22
二、投资活动产生的现金流量:
  收回投资收到的现金321,057,511.35143,290,212.96744,978,159.38320,118,814.75
  取得投资收益收到的现金10,980,362.626,638,305.8628,784,403.223,099,019.24
  处置固定资产、无形资产和其他长期资产收回的现金净额234,222.65150,0005,250,735.8361,577.85
  处置子公司及其他营业单位收到的现金净额779,063.58-1,576,703.75153,534.52
  投资活动现金流入小计333,051,160.2150,078,518.82780,590,002.13343,732,946.36
  购建固定资产、无形资产和其他长期资产支付的现金85,183,922.7346,490,321.64156,401,671.553,150,231.26
  投资支付的现金360,930,240247,535,688.18898,053,399.82397,911,289.88
  取得子公司及其他营业单位支付的现金1,573,272.51---
  支付其他与投资活动有关的现金36,482,719.1-74,253,121.3432,283,911.49
  投资活动现金流出小计484,170,154.34294,026,009.821,128,708,192.66483,345,432.63
  投资活动产生的现金流量净额-151,118,994.14-143,947,491-348,118,190.53-139,612,486.27
三、筹资活动产生的现金流量:
  吸收投资收到的现金30,240---
  取得借款收到的现金689,408,028.66485,000,0001,069,878,531.4781,987,585.81
  筹资活动现金流入小计689,438,268.66485,000,0001,069,878,531.4781,987,585.81
  偿还债务支付的现金586,200,000463,000,0001,148,576,001.62707,690,000
  分配股利、利润或偿付利息支付的现金50,510,131.212,069,613.8115,879,362.74111,394,076.7
  其中:子公司支付给少数股东的股利、利润--4,900,0004,900,000
  支付其他与筹资活动有关的现金939,584.35438,828.8919,088,655.0316,858,058.3
  筹资活动现金流出小计637,649,715.56465,508,442.691,283,544,019.39835,942,135
  筹资活动产生的现金流量净额51,788,553.119,491,557.31-213,665,487.99-53,954,549.19
四、汇率变动对现金及现金等价物的影响-496,657.21-85,746.955,892,537.01-3,429,033.05
五、现金及现金等价物净增加额47,358,938.17-75,687,930.3-132,893,085.6952,910,976.71
  加:期初现金及现金等价物余额350,282,566.24350,282,566.24483,175,651.93483,175,651.93
  期末现金及现金等价物余额397,641,504.41274,594,635.94350,282,566.24536,086,628.64
补充资料:
  净利润102,778,791.96-229,878,784.29-
  资产减值准备3,429,714.9-41,793,091.25-
  固定资产和投资性房地产折旧37,944,641.18-77,284,957.17-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧37,944,641.18-77,284,957.17-
  无形资产摊销6,006,111.27-9,947,003.03-
  长期待摊费用摊销1,937,994.69-5,801,094.1-
  处置固定资产、无形资产和其他长期资产的损失589,649.32--1,594,616.6-
  固定资产报废损失840,720.33-5,322,809.28-
  公允价值变动损失-15,721,758.28--149,352.07-
  财务费用6,821,749.42--16,045,554.49-
  投资损失-1,545,195.32--1,176,689.23-
  递延所得税-2,175,885.08--5,977,876.24-
  其中:递延所得税资产减少-4,703,234.29--5,095,096.41-
    递延所得税负债增加2,527,349.21--882,779.83-
  存货的减少11,815,654.21-3,898,650.18-
  经营性应收项目的减少-91,082,617.81-23,657,303.07-
  经营性应付项目的增加59,417,083.52-30,243,283.9-
  现金的期末余额397,641,504.41-350,282,566.24-
  减:现金的期初余额350,282,566.24-483,175,651.93-
  现金及现金等价物的净增加额47,358,938.17--132,893,085.69-
公告日期2025-08-302025-04-302025-04-302024-10-31
审计意见(境内)保留意见
TOP↑